Literature DB >> 16786875

Antimicrobial properties of the chelating agent EDTA on Streptococcal bovine mastitis isolates.

Jeffrey S Reidmiller1, Wayne L Smith, Mary M Sawyer, Bennie I Osburn, Jeffery L Stott, James S Cullor.   

Abstract

To determine the efficacy of the chelating agent EDTA on microbial growth, separate cultures of two streptococcal bovine mastitis isolates, Streptococcus agalactiae and Streptococcus uberis, were exposed to known concentrations of EDTA. Bacterial cultures of 10(8) CFU/ml were exposed to concentrations of EDTA ranging from 30 to 100 mM in an in-vitro-milk environment. Multiple replications of cultures exposed to EDTA were plated during a two-hour time course. A concentration of 100 mM EDTA resulted in a 90% reduction of S. agalactiae and a 99% reduction of S. uberis. Under these experimental conditions, EDTA treatments in cultures of both isolates exhibited from 1 to 2 log reductions suggesting that EDTA is a potentially effective antimicrobial against streptococcal isolates implicated in causing bovine mastitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16786875     DOI: 10.4315/0362-028x-69.6.1460

Source DB:  PubMed          Journal:  J Food Prot        ISSN: 0362-028X            Impact factor:   2.077


  3 in total

1.  Lactobacillus rhamnosus and Staphylococcus epidermidis in gut microbiota: in vitro antimicrobial resistance.

Authors:  Pamela Hindieh; Joseph Yaghi; André El Khoury; Ali Chokr; Ali Atoui; Nicolas Louka; Jean Claude Assaf
Journal:  AMB Express       Date:  2022-10-03       Impact factor: 4.126

2.  Sample storage conditions significantly influence faecal microbiome profiles.

Authors:  Jocelyn M Choo; Lex E X Leong; Geraint B Rogers
Journal:  Sci Rep       Date:  2015-11-17       Impact factor: 4.379

3.  Long-term stability of microbiome diversity and composition in fecal samples stored in eNAT medium.

Authors:  Rebecca R Young; Kirsten Jenkins; Felix Araujo-Perez; Patrick C Seed; Matthew S Kelly
Journal:  Microbiologyopen       Date:  2020-05-10       Impact factor: 3.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.